Inj, mannitol, 250 mg
Products billed under this code include Mannitol.
Payment limit per 250 MG, by effective quarter, 4Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Mannitol.
Payment limit per 250 MG, by effective quarter, 4Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Mannitol | Henry Schein Inc. | 00404-9905-50 | 50 | $5.60 |
| Mannitol | Pfizer Inc | 00409-4031-01 | 1250 | $140.00 |
| Mannitol | ICu Medical Inc. | 00990-7715-02 | 4800 | $537.60 |
| Mannitol | ICu Medical Inc. | 00990-7715-03 | 4800 | $537.60 |
| Mannitol | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1468-01 | 50 | $5.60 |
| Mannitol | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1468-03 | 1250 | $140.00 |
| Mannitol | FreseniUS Kabi USA, LLC | 63323-0024-25 | 50 | $5.60 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.112 | +$0.041 | 250 MG | Inj, mannitol, 250 mg | v1, posted September 17, 2026 |
| 3Q26 | $0.071 | +$0.018 | 250 MG | Inj, mannitol, 250 mg | v1, posted September 15, 2026 |
| 2Q26 | $0.053 | −$0.007 | 250 MG | Inj, mannitol, 250 mg | v1, posted September 15, 2026 |
| 1Q26 | $0.06 | −$0.001 | 250 MG | Inj, mannitol, 250 mg | v1, posted September 15, 2026 |
| 4Q25 | $0.061 | – | 250 MG | Inj, mannitol, 250 mg | v1, posted September 8, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.